HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Massachusetts General Hospital
Study ID
NCT05205954
Status
Recruiting
Apply to this trial

Conditions

  • Cirrhosis
  • End Stage Liver DIsease
  • Liver Cirrhosis
  • Liver Disease Chronic

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Hepatology Home Hospital — BEHAVIORAL
    The Hepatology Home Hospital intervention entails the following: patient-reported symptoms and vital signs with appropriate triggers for phone calls and home visits, and regular communication with hepatology clinicians regarding care delivered at home to ensure continuity of care.

Study Details

This research study is evaluating a program that entails a healthcare at home intervention for people with advanced liver disease.

Key Dates

Start date
Jul 21, 2025
Status verified
Jul 2025
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Hepatology Hospital at Home
    Patients with advanced liver disease receive hospital-level care in the home setting

Primary Outcome Measure

Escalation Rate [ Time Frame: 18 months ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Massachusetts General HospitalBostonMassachusetts02114
Will Munroe, BA
[email protected]
617-726-0161
Grace Bizup, BA
[email protected]
617-724-1316
Nneka Ufere, MD, MSCE (PRINCIPAL_INVESTIGATOR)
Massachusetts General HospitalBostonMassachusetts02114-

Find similar trials in Boston, MA

By research site
Massachusetts General Hospital· Boston, MA

Related Studies